Antidepressant potentiation of 5-hydroxytryptophan by L-deprenil in affective illness
- 1 June 1980
- journal article
- research article
- Published by Elsevier in Journal of Affective Disorders
- Vol. 2 (2) , 137-146
- https://doi.org/10.1016/0165-0327(80)90013-0
Abstract
No abstract availableThis publication has 25 references indexed in Scilit:
- Experiences with L-deprenyl in ParkinsonismJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1978
- IMPLICATIONS OF COMBINED TREATMENT WITH 'MADOPAR' AND L-DEPRENIL IN PARKINSON'S DISEASEThe Lancet, 1977
- TRYPTOPHAN-NICOTINAMIDE COMBINATION IN DEPRESSIONThe Lancet, 1977
- The potentiation of the anti akinetic effect after L-Dopa treatment by an inhibitor of Mao-B, deprenilJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1975
- PLASMA CONCENTRATION OF AMITRIPTYLINE AND CLINICAL RESPONSEThe Lancet, 1972
- Diagnostic Criteria for Use in Psychiatric ResearchArchives of General Psychiatry, 1972
- SEQUENTIAL COMPARISON OF L-TRYPTOPHAN WITH E.C.T. IN SEVERE DEPRESSIONThe Lancet, 1970
- TYRAMINE IN CHEESE RELATED TO HYPERTENSIVE CRISES AFTER MONOAMINE-OXIDASE INHIBITIONThe Lancet, 1965
- HYPERTENSIVE CRISIS DUE TO MONOAMINE-OXIDASE INHIBITORSThe Lancet, 1963
- POTENTIATION OF THE ANTIDEPRESSIVE EFFECT OF A MONOAMINE-OXIDASE INHIBITOR BY TRYPTOPHANThe Lancet, 1963